BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 22193888)

  • 1. The cell biology of TRIM5α.
    Lukic Z; Campbell EM
    Curr HIV/AIDS Rep; 2012 Mar; 9(1):73-80. PubMed ID: 22193888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolation of an active Lv1 gene from cattle indicates that tripartite motif protein-mediated innate immunity to retroviral infection is widespread among mammals.
    Ylinen LM; Keckesova Z; Webb BL; Gifford RJ; Smith TP; Towers GJ
    J Virol; 2006 Aug; 80(15):7332-8. PubMed ID: 16840314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cellular and antiviral functions of TRIM5α].
    Khalfi S; Mérindol N; Berthoux L
    Virologie (Montrouge); 2020 Dec; 24(6):369-380. PubMed ID: 33441289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p62/sequestosome-1 associates with and sustains the expression of retroviral restriction factor TRIM5alpha.
    O'Connor C; Pertel T; Gray S; Robia SL; Bakowska JC; Luban J; Campbell EM
    J Virol; 2010 Jun; 84(12):5997-6006. PubMed ID: 20357094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent insights into the mechanism and consequences of TRIM5α retroviral restriction.
    Sastri J; Campbell EM
    AIDS Res Hum Retroviruses; 2011 Mar; 27(3):231-8. PubMed ID: 21247355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The B30.2(SPRY) domain of the retroviral restriction factor TRIM5alpha exhibits lineage-specific length and sequence variation in primates.
    Song B; Gold B; O'Huigin C; Javanbakht H; Li X; Stremlau M; Winkler C; Dean M; Sodroski J
    J Virol; 2005 May; 79(10):6111-21. PubMed ID: 15857996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclophilin A renders human immunodeficiency virus type 1 sensitive to Old World monkey but not human TRIM5 alpha antiviral activity.
    Keckesova Z; Ylinen LM; Towers GJ
    J Virol; 2006 May; 80(10):4683-90. PubMed ID: 16641261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TRIM5 acts as more than a retroviral restriction factor.
    de Silva S; Wu L
    Viruses; 2011 Jul; 3(7):1204-9. PubMed ID: 21866272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TRIM family proteins: retroviral restriction and antiviral defence.
    Nisole S; Stoye JP; Saïb A
    Nat Rev Microbiol; 2005 Oct; 3(10):799-808. PubMed ID: 16175175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Control of viral infectivity by tripartite motif proteins.
    Towers GJ
    Hum Gene Ther; 2005 Oct; 16(10):1125-32. PubMed ID: 16218773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteasome inhibition reveals that a functional preintegration complex intermediate can be generated during restriction by diverse TRIM5 proteins.
    Anderson JL; Campbell EM; Wu X; Vandegraaff N; Engelman A; Hope TJ
    J Virol; 2006 Oct; 80(19):9754-60. PubMed ID: 16973579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. General Model for Retroviral Capsid Pattern Recognition by TRIM5 Proteins.
    Wagner JM; Christensen DE; Bhattacharya A; Dawidziak DM; Roganowicz MD; Wan Y; Pumroy RA; Demeler B; Ivanov DN; Ganser-Pornillos BK; Sundquist WI; Pornillos O
    J Virol; 2018 Feb; 92(4):. PubMed ID: 29187540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unique features of TRIM5alpha among closely related human TRIM family members.
    Li X; Gold B; O'hUigin C; Diaz-Griffero F; Song B; Si Z; Li Y; Yuan W; Stremlau M; Mische C; Javanbakht H; Scally M; Winkler C; Dean M; Sodroski J
    Virology; 2007 Apr; 360(2):419-33. PubMed ID: 17156811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The control of viral infection by tripartite motif proteins and cyclophilin A.
    Towers GJ
    Retrovirology; 2007 Jun; 4():40. PubMed ID: 17565686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trafficking of some old world primate TRIM5α proteins through the nucleus.
    Diaz-Griffero F; Gallo DE; Hope TJ; Sodroski J
    Retrovirology; 2011 May; 8():38. PubMed ID: 21575157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional evidence for the involvement of microtubules and dynein motor complexes in TRIM5α-mediated restriction of retroviruses.
    Pawlica P; Le Sage V; Poccardi N; Tremblay MJ; Mouland AJ; Berthoux L
    J Virol; 2014 May; 88(10):5661-76. PubMed ID: 24600008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Restriction of retroviral replication by APOBEC3G/F and TRIM5alpha.
    Huthoff H; Towers GJ
    Trends Microbiol; 2008 Dec; 16(12):612-9. PubMed ID: 18976920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TRIM5 structure, HIV-1 capsid recognition, and innate immune signaling.
    Grütter MG; Luban J
    Curr Opin Virol; 2012 Apr; 2(2):142-50. PubMed ID: 22482711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytoplasmic body component TRIM5{alpha} requires lipid-enriched microdomains for efficient HIV-1 restriction.
    Ohmine S; Sakuma R; Sakuma T; Thatava T; Solis GP; Ikeda Y
    J Biol Chem; 2010 Nov; 285(45):34508-17. PubMed ID: 20810659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retrovirus resistance factors Ref1 and Lv1 are species-specific variants of TRIM5alpha.
    Hatziioannou T; Perez-Caballero D; Yang A; Cowan S; Bieniasz PD
    Proc Natl Acad Sci U S A; 2004 Jul; 101(29):10774-9. PubMed ID: 15249685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.